Oncotarget

Research Papers:

This article has been corrected. Correction in: Oncotarget. 2023; 14:104-104.

KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer

Keisuke Taniuchi _ and Mitsunari Ogasawara

PDF  |  Full Text  |  Supplementary Files  |  How to cite

Oncotarget. 2020; 11:131-147. https://doi.org/10.18632/oncotarget.27413

Metrics: PDF 1479 views  |   Full Text 2279 views  |   ?  


Abstract

Keisuke Taniuchi1,2 and Mitsunari Ogasawara1

1 Department of Gastroenterology and Hepatology, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan

2 Department of Endoscopic Diagnostics and Therapeutics, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan

Correspondence to:

Keisuke Taniuchi,email: ktaniuchi@kochi-u.ac.jp

Keywords: RNA-binding protein; small nucleolar RNA; pancreatic cancer; cell invasion; metastasis

Received: July 22, 2019     Accepted: December 16, 2019     Published: January 14, 2020

ABSTRACT

KH-type splicing regulatory protein (KHSRP) is an RNA-binding protein implicated in a variety of cellular processes, including splicing in the nucleus and mRNA localization and degradation in the cytoplasm. The present study reports that KHSRP promotes invasiveness and metastasis of pancreatic cancer cells. KHSRP was localized in the nucleus and cell protrusions of pancreatic cancer cell lines. Suppression of KHSRP by small interfering RNA decreased the number of cell protrusions and inhibited invasiveness and metastasis of pancreatic cancer cells. KHSRP was localized in cytoplasmic RNA granules in pancreatic cancer cells, and RNA immunoprecipitation-sequencing analysis showed that the majority of enriched RNAs that immunoprecipitated with KHSRP were small nucleolar RNAs (snoRNAs). Specific KHSRP-bound snoRNAs, SNORA18 and SNORA22, associated with formation of cell protrusions. Consequently, SNORA18 and SNORA22 contributed to cell invasiveness and tumor metastasis. Our results provide insight into the link between KHSRP-bound snoRNAs and invasiveness and metastasis of pancreatic cancers. New therapies that prevent binding of KHSRP with specific snoRNAs may hold significant clinical promise.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 27413